Paper24419087
Role of CHD5 in human cancers: 10 years later.
Kolla V and 4 others. Cancer Res, 2014. Cited by 76 papers, by iCite.
Cite this record
ConductScience Library. Role of CHD5 in human cancers: 10 years later. Papers, record 24419087. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24419087
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| DNA Helicases | Major topic |
| Neoplasms | Major topic |
| Nerve Tissue Proteins | Major topic |
| Animals | |
| Humans | |
| Tumor Suppressor Proteins |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 CA039771 | NCI NIH HHS | United States | R01CA039771 | PubMed and NIH |
| CA039771 | NCI NIH HHS | United States | R01CA039771 | PubMed and NIH |
Source NIH RePORTER
References53
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12592387 | CHD5, a new member of the chromodomain gene family, is preferentially expressed in the nervous system. | Oncogene | 2003 | https://conductscience.org/library/papers/12592387 | PubMed |
| 2 | 24387342 | Therapeutic targets for neuroblastomas. | Expert Opin Ther Targets | 2014 | https://conductscience.org/library/papers/24387342 | PubMed |
| 3 | 23948251 | CHD5 is required for neurogenesis and has a dual role in facilitating gene expression and polycomb gene repression. | Dev Cell | 2013 | https://conductscience.org/library/papers/23948251 | PubMed |
| 4 | 19750230 | Distinct high-profile methylated genes in colorectal cancer. | PLoS One | 2009 | https://conductscience.org/library/papers/19750230 | PubMed |
| 5 | 22328561 | A three-gene expression signature model for risk stratification of patients with neuroblastoma. | Clin Cancer Res | 2012 | https://conductscience.org/library/papers/22328561 | PubMed |
| 6 | 23669186 | Gene methylation in gastric cancer. | Clin Chim Acta | 2013 | https://conductscience.org/library/papers/23669186 | PubMed |
| 7 | 15949564 | Molecular cytogenetic analysis of chromosomes 1 and 19 in glioma cell lines. | Cancer Genet Cytogenet | 2005 | https://conductscience.org/library/papers/15949564 | PubMed |
| 8 | 22855185 | Decreased expression of chromodomain helicase DNA-binding protein 5 is an unfavorable prognostic marker in patients with primary gallbladder carcinoma. | Clin Transl Oncol | 2013 | https://conductscience.org/library/papers/22855185 | PubMed |
| 9 | 17694084 | The human Mi-2/NuRD complex and gene regulation. | Oncogene | 2007 | https://conductscience.org/library/papers/17694084 | PubMed |
| 10 | 22186629 | CHD5, a tumor suppressor that is epigenetically silenced in lung cancer. | Lung Cancer | 2012 | https://conductscience.org/library/papers/22186629 | PubMed |
| 11 | 11889561 | CHD5 defines a new subfamily of chromodomain-SWI2/SNF2-like helicases. | Mamm Genome | 2002 | https://conductscience.org/library/papers/11889561 | PubMed |
| 12 | 21860208 | CHD5 Downregulation Associated with Poor Prognosis in Epithelial Ovarian Cancer. | Gynecol Obstet Invest | 2011 | https://conductscience.org/library/papers/21860208 | PubMed |
| 13 | 23954449 | CHD chromatin remodelling enzymes and the DNA damage response. | Mutat Res | 2013 | https://conductscience.org/library/papers/23954449 | PubMed |
| 14 | 23707602 | Downregulation of chromatin remodeling factor CHD5 is associated with a poor prognosis in human glioma. | J Clin Neurosci | 2013 | https://conductscience.org/library/papers/23707602 | PubMed |
| 15 | 19840376 | CHD5 is down-regulated through promoter hypermethylation in gastric cancer. | J Biomed Sci | 2009 | https://conductscience.org/library/papers/19840376 | PubMed |
| 16 | 17289567 | CHD5 is a tumor suppressor at human 1p36. | Cell | 2007 | https://conductscience.org/library/papers/17289567 | PubMed |
| 17 | 22294723 | Mechanisms of CHD5 Inactivation in neuroblastomas. | Clin Cancer Res | 2012 | https://conductscience.org/library/papers/22294723 | PubMed |
| 18 | 16959974 | The consensus coding sequences of human breast and colorectal cancers. | Science | 2006 | https://conductscience.org/library/papers/16959974 | PubMed |
| 19 | 23340908 | The NuRD architecture. | Cell Mol Life Sci | 2013 | https://conductscience.org/library/papers/23340908 | PubMed |
| 20 | 23318260 | Chd5 requires PHD-mediated histone 3 binding for tumor suppression. | Cell Rep | 2013 | https://conductscience.org/library/papers/23318260 | PubMed |
Cited by64
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 76 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42283962 | CHD6 promotes triple-negative breast cancer progression and is associated with PI3K/AKT and MAPK pathways. | Int J Clin Oncol | 2026 | https://conductscience.org/library/papers/42283962 | PubMed |
| 42072710 | Chromatin Remodeling, DNA Double-Strand Break Repair, and Human Disease: How a Breakup Changes You. | Biomolecules | 2026 | https://conductscience.org/library/papers/42072710 | PubMed |
| 41876493 | Vascular invasion-associated gene expression is detectable in pre-surgical biopsies of stage I lung adenocarcinoma. | Nat Commun | 2026 | https://conductscience.org/library/papers/41876493 | PubMed |
| 41584030 | New Insights into the Relation between Cognition, Behavior, and the CHD5 Gene: A Case-Report of an Adult Male with Parenti-Mignot Neurodevelopmental Syndrome. | Mol Syndromol | 2025 | https://conductscience.org/library/papers/41584030 | PubMed |
| 41487470 | The role of positive feedback loop between LINC00862 and RBM47 in hepatocellular carcinoma suppression. | Genes Dis | 2026 | https://conductscience.org/library/papers/41487470 | PubMed |
| 38891074 | The Role of Mesenchymal Reprogramming in Malignant Clonal Evolution and Intra-Tumoral Heterogeneity in Glioblastoma. | Cells | 2024 | https://conductscience.org/library/papers/38891074 | PubMed |
| 38809626 | Comprehensive Analysis of the Expression, Prognosis, and Immune Infiltrates for Chromodomain-Helicase-DNA-Binding Proteins in Breast Tumor. | Asian Pac J Cancer Prev | 2024 | https://conductscience.org/library/papers/38809626 | PubMed |
| 38367868 | The therapeutic potential of targeting the CHD protein family in cancer. | Pharmacol Ther | 2024 | https://conductscience.org/library/papers/38367868 | PubMed |
| 38001317 | Context-specific functions of chromatin remodellers in development and disease. | Nat Rev Genet | 2024 | https://conductscience.org/library/papers/38001317 | PubMed |
| 37521848 | Pathway analysis of smoking-induced changes in buccal mucosal gene expression. | Egypt J Med Hum Genet | 2022 | https://conductscience.org/library/papers/37521848 | PubMed |
| 37440096 | CHD5 gene variant predicts leptomeningeal metastasis after surgical resection of brain metastases of breast cancer. | J Neurooncol | 2023 | https://conductscience.org/library/papers/37440096 | PubMed |
| 37372954 | p53 Affects Zeb1 Interactome of Breast Cancer Stem Cells. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37372954 | PubMed |
| 36913741 | The Chd4 Helicase Regulates Chromatin Accessibility and Gene Expression Critical for β-Cell Function In Vivo. | Diabetes | 2023 | https://conductscience.org/library/papers/36913741 | PubMed |
| 36856811 | Identification of a novel eighteen-gene signature of recurrent metastasis neuroblastoma. | J Mol Med (Berl) | 2023 | https://conductscience.org/library/papers/36856811 | PubMed |
| 36776288 | CHD1, a multifaceted epigenetic remodeler in prostate cancer. | Front Oncol | 2023 | https://conductscience.org/library/papers/36776288 | PubMed |
| 36408932 | CHD6 promotes broad nucleosome eviction for transcriptional activation in prostate cancer cells. | Nucleic Acids Res | 2022 | https://conductscience.org/library/papers/36408932 | PubMed |
| 35955624 | Pan-Cancer Analysis Identifies CHD5 as a Potential Biomarker for Glioma. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35955624 | PubMed |
| 35768791 | Mutations of 1p genes do not consistently abrogate tumor suppressor functions in 1p-intact neuroblastoma. | BMC Cancer | 2022 | https://conductscience.org/library/papers/35768791 | PubMed |
| 35524943 | CHD Chromatin Remodeling Protein Diversification Yields Novel Clades and Domains Absent in Classic Model Organisms. | Genome Biol Evol | 2022 | https://conductscience.org/library/papers/35524943 | PubMed |
| 34789839 | CHD5 inhibits metastasis of neuroblastoma. | Oncogene | 2022 | https://conductscience.org/library/papers/34789839 | PubMed |
Genes29
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/24419087
GET https://conductscience.org/api/papers/v1/24419087/references?page=2